Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 February 2008, Vol. 111, No. 3, pp. 1437-1447.
Prepublished online as a Blood First Edition Paper on November 8, 2007; DOI 10.1182/blood-2007-07-100404.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-07-100404v1
111/3/1437    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaknin, I.
Right arrow Articles by Baniyash, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaknin, I.
Right arrow Articles by Baniyash, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted July 10, 2007
Accepted November 5, 2007

A common pathway mediated through Toll-like receptors leads to T and natural killer cell immunosuppression

Ilan Vaknin, Liora Blinder, Lynn Wang, Roi Gazit, Elena Shapira, Olga Genina, Mark Pines, Eli Pikarsky, and Michal Baniyash*

The Lautenberg Center for General and Tumor Immunology, The Hebrew University Hadassah Medical School, Jerusalem, Israel
Institute of Animal Science, ARO, The Volcani Center, Rehovot, Israel
Department of Pathology, Hebrew University Hadassah Medical School, Jerusalem, Israel

* Corresponding author; email: baniyash{at}cc.huji.ac.il.

T and NK cell immunosuppression associated with {zeta}-chain down-regulation has been described in cancer, autoimmune and infectious diseases. However, the precise stimuli leading to this bystander phenomenon in such different pathogen-dependent and sterile pathologies remained unresolved. Here, we demonstrate that TLRs play a major role in the induction of innate and adaptive immune system suppression; repetitive administration of single TLR 2, 3, 4 or 9 agonists, which do not exhibit any virulent or immune invasive properties, was sufficient to induce a bystander NK and T cell immunosuppression associated with {zeta}-chain down-regulation mediated by myeloid suppressor cells, as observed in the course of active pathologies. We identified a 35 amino acid region within the {zeta}-chain as being responsible for its degradation under TLR-mediated chronic inflammation. Furthermore, we provide evidence that {zeta}-chain levels could serve as a biomarker for chronic inflammation-dependent immunosuppression. Thus, while acute TLR-mediated activation could be beneficial in clearing pathogens or may serve as an immune adjuvant, such activation could be detrimental under sustained conditions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020